We'll have to agree to disagree.My understanding is that there...

We'll have to agree to disagree.

My understanding is that there will be no more results of any sort from the phase 3 trials until 2010. The Data Safety Monitoring Board is an independent body that can review the data an an early stage, such as the recent announcement re dose and whether the trial should continue. It is part of FDA regulations that a Data Safety Monitoring Board is involved in trials like this and it allows DSMBs responsibilities for some scientific (eg dosage) or safety (is the drug working/safe) issues. Perhaps that's where the mention of the FDA came in.